Banque Cantonale Vaudoise Cooper Companies, Inc. Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$306.88 - $380.0 $1.51 Million - $1.87 Million	4,922 Added 195.16%	7,444 $2.82 Million
Q3 2023 Nov 08, 2023	BUY	$315.92 - $397.36 $512,422 - $644,517	1,622 Added 180.22%	2,522 $802,000
Q2 2022 Aug 02, 2022	SELL	$301.4 - $428.42 $60,279 - $85,684	-200 Reduced 18.18%	900 $281,000
Q3 2021 Oct 29, 2021	SELL	$396.76 - $455.92 $578,079 - $664,275	-1,457 Reduced 56.98%	1,100 $455,000
Q2 2021 Aug 11, 2021	BUY	$372.36 - $412.07 $542,528 - $600,385	1,457 Added 132.45%	2,557 $1.01 Million
Q1 2021 May 11, 2021	SELL	$357.26 - $392.57 $107,178 - $117,771	-300 Reduced 21.43%	1,100 $422,000
Q2 2020 Jul 22, 2020	SELL	$270.93 - $320.3 $216,744 - $256,240	-800 Reduced 36.36%	1,400 $397,000
Q4 2019 Feb 10, 2020	BUY	$281.18 - $322.05 $618,596 - $708,510	2,200 New	2,200 $707,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.